IXABEPILONE for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where IXABEPILONE was used for Neoplasm malignant.
Most Reported Side Effects for IXABEPILONE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Anaemia | 55 | 15.0% | 7 | 31 |
| Death | 49 | 13.3% | 49 | 16 |
| Neutrophil count decreased | 48 | 13.0% | 4 | 29 |
| White blood cell count decreased | 45 | 12.2% | 6 | 29 |
| Pseudocirrhosis | 31 | 8.4% | 14 | 4 |
| Fatigue | 30 | 8.2% | 4 | 15 |
| Vomiting | 30 | 8.2% | 9 | 19 |
| Malignant neoplasm progression | 26 | 7.1% | 9 | 3 |
| Nausea | 25 | 6.8% | 7 | 15 |
| Platelet count decreased | 25 | 6.8% | 4 | 16 |
| Portal hypertension | 23 | 6.3% | 7 | 1 |
| Dyspnoea | 22 | 6.0% | 5 | 12 |
| Disease progression | 18 | 4.9% | 3 | 4 |
| Dehydration | 17 | 4.6% | 3 | 13 |
| Hypokalaemia | 17 | 4.6% | 2 | 16 |
Other Indications for IXABEPILONE
Breast cancer metastatic (107)
Breast cancer (52)
Product used for unknown indication (37)
Endometrial cancer (36)
Ovarian cancer (12)
Papillary serous endometrial carcinoma (12)
Non-small cell lung cancer (10)
Endometrial adenocarcinoma (8)
Invasive ductal breast carcinoma (8)
Breast cancer female (7)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)